Alliancebernstein L.P. Aerie Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$6.37 - $15.23 $29,302 - $70,058	4,600 Added 7.11%	69,300 $1.05 Million
Q1 2022 May 13, 2022	BUY	$5.64 - $9.8 $1,128 - $1,960	200 Added 0.31%	64,700 $589,000
Q2 2021 Jul 30, 2021	BUY	$15.16 - $18.97 $81,864 - $102,438	5,400 Added 9.14%	64,500 $1.03 Million
Q1 2021 May 06, 2021	SELL	$13.12 - $20.9 $93,152 - $148,390	-7,100 Reduced 10.73%	59,100 $1.06 Million
Q4 2020 Feb 08, 2021	SELL	$9.12 - $14.49 $45,599 - $72,450	-5,000 Reduced 7.02%	66,200 $894,000
Q3 2020 Nov 12, 2020	SELL	$10.46 - $14.46 $838,892 - $1.16 Million	-80,200 Reduced 52.97%	71,200 $838,000
Q2 2020 Aug 13, 2020	SELL	$12.0 - $16.13 $7.07 Million - $9.5 Million	-588,844 Reduced 79.55%	151,400 $2.24 Million
Q1 2020 May 14, 2020	BUY	$11.84 - $25.52 $928,078 - $2 Million	78,385 Added 11.84%	740,244 $9.99 Million
Q4 2019 Feb 18, 2020	BUY	$17.72 - $25.1 $2.08 Million - $2.95 Million	117,437 Added 21.57%	661,859 $16 Million
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $768,912 - $1.17 Million	-41,766 Reduced 7.13%	544,422 $10.5 Million
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $237,380 - $395,032	-8,194 Reduced 1.38%	586,188 $17.3 Million
Q1 2019 May 14, 2019	BUY	$36.32 - $49.25 $653,723 - $886,450	17,999 Added 3.12%	594,382 $28.2 Million
Q4 2018 Feb 13, 2019	BUY	$33.0 - $60.04 $3.5 Million - $6.37 Million	106,047 Added 22.55%	576,383 $20.8 Million
Q3 2018 Nov 08, 2018	BUY	$56.15 - $73.9 $3 Million - $3.95 Million	53,484 Added 12.83%	470,336 $28.9 Million
Q2 2018 Aug 13, 2018	SELL	$47.85 - $70.45 $952,549 - $1.4 Million	-19,907 Reduced 4.56%	416,852 $28.2 Million
Q1 2018 May 14, 2018	BUY	$51.15 - $61.0 $3.36 Million - $4.01 Million	65,683 Added 17.7%	436,759 $23.7 Million
Q4 2017 Feb 13, 2018	SELL	$50.85 - $65.1 $2.22 Million - $2.84 Million	-43,654 Reduced 10.53%	371,076 $22.2 Million
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $20.2 Million - $24.9 Million	414,730	414,730 $20.2 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account